New Zealand puts focus on designing mRNA vaccine for Staphylococcus bug
Vaccines | News | 0 Comment | 21 Mar, 2022
A group of scientists at the University of Auckland in New Zealand are working towards developing an mRNA-based vaccine ...Read more
“Our COVID-19 Vax Efficacy is Promising; Lyme disease & Chikungunya Shots in pipeline"
Vaccines | Opinion | 2 Comment | 07 Mar, 2022
What are the unique highlights of the COVID-19 vaccine- VLA2001 under trial? While different companies have taken vario...Read more
Sinovac inks agreement with Ministry of Public Health of Ecuador to build vaccine factory
Vaccines | News | 0 Comment | 28 Feb, 2022
Sinovac Biotech, based in China, has signed a letter of agreement with the Ecuadorian Ministry of Public Healt...Read more
WHO establishes global bio-manufacturing training hub in Korea
Vaccines | News | 0 Comment | 25 Feb, 2022
The World Health Organization (WHO), the Republic of Korea and the WHO Academy have announced the establishment of a glo...Read more
New vaccine trial in Australia evaluates fractional COVID-19 booster shots
Vaccines | News | 0 Comment | 24 Feb, 2022
The Coalition for Epidemic Preparedness Innovations (CEPI) in Norway and the Murdoch Children’s Research Institute...Read more
China approves CanSinoBIO's Convidecia as heterologous booster for COVID-19
Vaccines | News | 0 Comment | 21 Feb, 2022
CanSino Biologics Inc. has announced that its Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)...Read more
Singapore grants interim authorisation for Novavax COVID-19 vaccine
Vaccines | News | 0 Comment | 18 Feb, 2022
The Health Sciences Authority (HSA) has granted an interim authorisation under the Pandemic Special Access Route (PSAR) ...Read more
Korea to run training programme on vaccines and biologics development
Vaccines | News | 0 Comment | 17 Feb, 2022
The International Vaccine Institute (IVI) has been designated by the Ministry of Health and Welfare (MOHW), Republic of ...Read more
Australia provisionally approves Moderna's COVID-19 vaccine for 6-11 years old
Vaccines | News | 0 Comment | 17 Feb, 2022
The Therapeutic Goods Administration (TGA) in Australia has provisionally approved the Moderna COVID-19 vaccine, SPIKEVA...Read more
China expands collaboration to develop COVID-19 multi-variant vaccine
Vaccines | News | 0 Comment | 10 Feb, 2022
Norway-based CEPI, the Coalition for Epidemic Preparedness Innovations, has announced that it will expand its collaborat...Read more
Hong Kong suggests mRNA vaccinations to tackle COVID-19 variants
Vaccines | News | 0 Comment | 09 Feb, 2022
Researchers at AIDS Institute, Department of Microbiology, LKS Faculty of Medicine of The University of Hong Kong (HKUMe...Read more
China reports better antibody production with intradermal vaccination than intramuscular
Vaccines | News | 0 Comment | 08 Feb, 2022
Intradermal COVID-19 vaccination studies are emerging in a global effort to multiply available doses by harnessing skin ...Read more
Russia's Sputnik Light vaccine receives authorisation in India
Vaccines | News | 0 Comment | 07 Feb, 2022
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) has announced that the Russian one-shot ...Read more
“Chinese and Russian vaccines have been disappointing relative to their overall effectiveness”
Vaccines | Opinion | 2 Comment | 06 Feb, 2022
What are your views on the ongoing threat being imposed by the COVID-19 variants across the globe? How can those be best...Read more
CEPI lays focus on developing heat-stable vaccine technology
Vaccines | News | 0 Comment | 04 Feb, 2022
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) has launched a new 'Call for Proposals' to...Read more
New Zealand gives provisional nod to first protein-based COVID-19 vaccine
Vaccines | News | 0 Comment | 04 Feb, 2022
US-based Novavax, Inc. has announced that New Zealand's Medsafe has granted provisional approval of NVX-CoV237...Read more
Korean firm EuBiologics receives approval for Ph III trial of COVID-19 vaccine
Vaccines | News | 0 Comment | 04 Feb, 2022
EuBiologics, a South Korean biotech company, has announced that EuCorVac-19, a COVID-19 vaccine candidate obtained appro...Read more
How IP Nitty-gritties Hinder Universal Immunisation?
Vaccines | Analysis | By Ayesha Siddiqui | 1 Comment | 04 Feb, 2022
The coronavirus crisis which has enraged the world has also opened up debates around IP and public health. The gen...Read more